Cargando…
Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management
Agranulocytosis is a rare but serious complication of antithyroid drug therapy, and an up-to-date understanding of this topic is important. Both direct toxicity and immune-mediated responses have been described as possible mechanisms. Some major susceptibility loci have recently been identified, whi...
Autores principales: | Vicente, Nuno, Cardoso, Luís, Barros, Luísa, Carrilho, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318340/ https://www.ncbi.nlm.nih.gov/pubmed/28105610 http://dx.doi.org/10.1007/s40268-017-0172-1 |
Ejemplares similares
-
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Antithyroid drug induced agranulocytosis: what still we need to learn ?
por: Chaudhry, Liaqat Ali, et al.
Publicado: (2016) -
Antithyroid drugs induced agranulocytosis and multiple myeloma:
case report and general considerations
por: Dănciulescu Miulescu, R, et al.
Publicado: (2013) -
Erratum: antithyroid drug induced agranulocytosis: what still we need to learn?
Publicado: (2016) -
MICA polymorphisms associated with antithyroid drug‐induced agranulocytosis in the Chinese Han population
por: Gong, Xiaojuan, et al.
Publicado: (2020)